EUVIMEDEUVIMED entdecken
Crossref

Clinical Characteristics and Outcomes of Hypertrophic Cardiomyopathy Associated With Thin Filament Variants: Insights From the SHaRe Registry

Alessia Argirò iD, Joshua K Meisner iD, Eric D Adler iD, Edoardo Bertero iD, Niccolò Maurizi iD, Brian L Claggett iD, Neal K Lakdawala iD, Anjali T Owens iD, Thomas D Ryan iD, Erin M Miller iD, Sara Saberi iD, Henning Bundgaard iD und 22 weitere

Circulation: Genomic and Precision Medicine · 2026

DOI: 10.1161/circgen.126.005696 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Genomic and Precision Medicine, 2026. Verfasst von Alessia Argirò und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Florence, Italy (A.A.). Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Conflicting evidence exists about whether sarcomeric hypertrophic cardiomyopathy (HCM) caused by genes encoding thin filament proteins ( TNNT2, TNNI3, ACTC, TPM1 , TNNC1 ; thin filament HCM) has a distinct clinical presentation and natural history from disease caused by the more commonly involved thick filament genes ( MYH7 , MYBPC3 , MYL2 , MYL3 ; thick filament HCM). METHODS: Retrospective analysis of the Sarcomeric Human Cardiomyopathy Registry. RESULTS: Four hundred eighty-eight patients with thin filament HCM were compared with 3494 patients with thick filament HCM. After controlling for age at diagnosis, sex, and proband status, thin filament HCM was associated with a higher risk of composite ventricular arrhythmias (hazard ratio, 1.48 [95% CI, 1.09–2.01]), cardiac arrest (hazard ratio, 2.02 [95% CI, 1.33–3.06]), and heart transplant or left ventricular assist device implantation (hazard ratio, 2.18 [95% CI, 1.3–3.65]). Younger age at diagnosis was associated with an increased risk for the ventricular arrhythmia composite outcome in thin and thick filament HCM (hazard ratio, 0.93 [95% CI, 0.91–0.94]; hazard ratio, 0.93 [95% CI, 0.93–0.94]; age reported as 5-year increment). Within specific thin filament genes, an increased risk of arrhythmic events or heart transplant/left ventricular assist device implantation was evident for variants in TNNT2 amino acids 92 to 94 (odds ratio versus other TNNT2 variants; odds ratio, 3.02 [95% CI, 1.17–7.49]) and TNNI3 amino acids 191 to 210 (odds ratio versus other TNNI3 variants; odds ratio, 3.5 [95% CI, 1.58–8.02]). CONCLUSIONS: Thin filament HCM seems to carry a higher risk for ventricular arrhythmias and advanced heart failure compared with thick filament HCM. Integrating gene-level and intragene-level information may improve risk stratification in patients with HCM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicHumansFemaleMaleRegistriesMiddle AgedAdultRetrospective StudiesTropomyosinArrhythmias, CardiacTroponin T

Stichwörter der Autor:innen

cardiomyopathy, hypertrophiccardiomyopathy, hypertrophic, familialgenetic testingheart failure

Substanzen

TropomyosinTroponin T

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, University of Florence, Italy (A.A.).
  • Department of Pediatrics (J.K.M.), University of Michigan, Ann Arbor.
  • Division of Cardiovascular Medicine, UC San Diego Health, University of California (E.D.A.).
  • Cardiovascular Disease Unit, Cardiac, Thoracic and Vascular Department, IRCCS Ospedale Policlinico San Martino, Genova, Italy (E.B.).
  • Cardiomyopathy Unit, Department of General Cardiology, Careggi University Hospital, Florence, Italy (N.M., I.O.).
  • Service of Cardiology, Lausanne University Hospital and University of Lausanne, Switzerland (N.M.).

ORCID-Profile: Alessia Argirò, Joshua K Meisner, Eric D Adler, Edoardo Bertero, Niccolò Maurizi, Brian L Claggett, Neal K Lakdawala, Anjali T Owens, Thomas D Ryan, Erin M Miller, Sara Saberi, Henning Bundgaard, Anna Axelsson Raja, Joseph W Rossano, Kimberly Y Lin, Francesca Girolami, Michelle Michels, Peter-Paul Zwetsloot, Dominic J Abrams, Rachel Lampert, John C Stendahl, James Ware, Victoria N Parikh, Euan A Ashley, Jodie Ingles, Belinda Gray, Romi L Castillo, Jil C Tardiff, Lia Crotti, Alexandre Pereira, Carolyn Y Ho, Sharlene M Day, Adam S Helms, Iacopo Olivotto

Zitieren

APA

Argirò, A., Meisner, J. K., Adler, E. D., Bertero, E., Maurizi, N., Claggett, B. L., Lakdawala, N. K., Owens, A. T., Ryan, T. D., Miller, E. M., Saberi, S., Bundgaard, H., Axelsson Raja, A., Rossano, J. W., Lin, K. Y., Girolami, F., Michels, M., Zwetsloot, P. P., Abrams, D. J., …, & Olivotto, I. (2026). Clinical Characteristics and Outcomes of Hypertrophic Cardiomyopathy Associated With Thin Filament Variants: Insights From the SHaRe Registry. Circulation: Genomic and Precision Medicine. https://doi.org/10.1161/circgen.126.005696

Vancouver

Argirò A, Meisner JK, Adler ED, Bertero E, Maurizi N, Claggett BL, et al. Clinical Characteristics and Outcomes of Hypertrophic Cardiomyopathy Associated With Thin Filament Variants: Insights From the SHaRe Registry. Circulation: Genomic and Precision Medicine. 2026. doi:10.1161/circgen.126.005696

BibTeX
@article{Argir2026,
  author = {Argirò, Alessia and Meisner, Joshua K and Adler, Eric D and Bertero, Edoardo and Maurizi, Niccolò and Claggett, Brian L and Lakdawala, Neal K and Owens, Anjali T and Ryan, Thomas D and Miller, Erin M and Saberi, Sara and Bundgaard, Henning and Axelsson Raja, Anna and Rossano, Joseph W and Lin, Kimberly Y and Girolami, Francesca and Michels, Michelle and Zwetsloot, Peter-Paul and Abrams, Dominic J and Lampert, Rachel and Stendahl, John C and Ware, James and Parikh, Victoria N and Ashley, Euan A and Ingles, Jodie and Gray, Belinda and Castillo, Romi L and Tardiff, Jil C and Crotti, Lia and Pereira, Alexandre and Ho, Carolyn Y and Day, Sharlene M and Helms, Adam S and Olivotto, Iacopo},
  title = {Clinical Characteristics and Outcomes of Hypertrophic Cardiomyopathy Associated With Thin Filament Variants: Insights From the SHaRe Registry},
  journal = {Circulation: Genomic and Precision Medicine},
  year = {2026},
  doi = {10.1161/circgen.126.005696}
}
Kostenlos starten →